Profil
Geoffrey von Maltzahn was the founder of Expedition Medicines, Inc. (2022), serving as Director; Generate Biomedicines, Inc. (2018), serving as Co-Chief Executive Officer; Seres Therapeutics, Inc. (2010), serving as Chief Technology Officer; Axcella Health, Inc. (2008), serving as Vice President-Discovery; Kaleido Biosciences, Inc. (2015), serving as Director; Mirai Bio (2021), serving as Director; Tessera Therapeutics, Inc. (2018), serving as Chairman; Quotient Therapeutics Ltd. (2022), serving as Chairman; and Indigo Ag, Inc. (2013), serving as Chief Innovation Officer & Director.
Dr. von Maltzahn is also the founder of Resonance Therapeutics,Sienna Biopharmaceuticals, Inc...
Dr. von Maltzahn is currently General Partner at Flagship Pioneering, LLC since 2009.
Former positions include President, Chief Executive Officer & Director at Cobalt Biomedicine, Inc.; Independent Director at Sana Biotechnology, Inc. from 2019 to 2021; and Vice President-Corporate Development at Essentient, Inc. Education includes an undergraduate degree (2003) and doctorate (2010) from Massachusetts Institute of Technology, and a graduate degree (2005) from the University of California San Diego.
Postes actifs de Geoffrey von Maltzahn
| Sociétés | Poste | Début |
|---|---|---|
Resonance Therapeutics
Resonance Therapeutics Medical/Nursing ServicesHealth Services Develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics | Fondateur | 17/09/2009 |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01/01/2009 |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Fondateur | 01/01/2018 |
Anciens postes connus de Geoffrey von Maltzahn
| Sociétés | Poste | Fin |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Fondateur | 15/03/2022 |
| SANA BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 01/09/2021 |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Directeur Général | 01/02/2019 |
Essentient, Inc.
Essentient, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transforming global nutrition | Corporate Officer/Principal | 17/02/2014 |
| AXCA HEALPAR | Fondateur | 01/01/2013 |
Formation de Geoffrey von Maltzahn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Resonance Therapeutics
Resonance Therapeutics Medical/Nursing ServicesHealth Services Develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics | Health Services |
Essentient, Inc.
Essentient, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transforming global nutrition | Commercial Services |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Indigo Ag, Inc.
Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Process Industries |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Sienna Biopharmaceuticals, Inc.
Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
Sana Biotechnology, Inc.
Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Health Technology |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Health Technology |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
















